BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
TGFB1
,
Fatty acid metabolic process
,
Obesity
,
Neuron
,
Laryngoscope
,
Fenofibrate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
HLA
NextBio Summary
General Info
Curated Studies
Most Correlated Studies
Dendritic cells from PBMCs with plasmacytoid and myeloid lineages
Peripheral blood monocytes response to soluble MHC Class II
CD8+ naive or activated T cells from PBMCs of dengue or dengue hemorrhagic patients
T cells gene expression profiling of enriched CD4+CD25+HLADR+ and CD4+CD25-
Macrophages infected with Salmonella typhimurium or Listeria monocytogenes
Explore Curated Studies Results
Literature
Most Relevant Literature
The HLA diversity of the Anthony Nolan register.
Correlation of the two most frequent HLA haplotypes in the Italian population to the differential re…
Insignificant effects of loss of heterozygosity in HLA in the efficacy of immune checkpoint blockade…
Easy-HLA: a validated web application suite to reveal the full details of HLA typing.
Characterization of the novel HLA-A*26:208 allele by sequencing-based typing.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Clinical Relevance of Typing HLA-DR7-DQ2
Safety Study of Peptide Cancer Vaccine To Treat HLA-A*02-positive Advanced Non-small Cell Lung Cance…
Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*24 or A*02-positive Advanced Solid Tumor…
HLA-mismatched MST vs HLA-matched NST for AML in Intermediate-risk
Maraviroc-Based GVHD Prophylaxis in HLA-Unrelated and HLA-Mismatched Related Transplantation
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ